Not on the menu-autophagy-independent clearance of prions

Prion

Volumn 7, Issue 4, 2013, Pages 286-290

  Browman, Duncan ^a   Zurzolo, Chiara ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

4 hydroxytamoxifen; Aggregates; Autophagy; Cholesterol; Neurodegenerative; Prion; Proteinopathies; Tamoxifen; Trafficking; U18666A

Indexed keywords

AFIMOXIFENE; CHOLESTEROL; ESTROGEN RECEPTOR; PRION PROTEIN; TAMOXIFEN;

ALZHEIMER DISEASE; ARTICLE; AUTOPHAGOSOME; AUTOPHAGY; CHOLESTEROL METABOLISM; CONFORMATION; DEGENERATIVE DISEASE; HUMAN; HUNTINGTON CHOREA; MACROAUTOPHAGY; PARKINSON DISEASE; PRION DISEASE; PROTEIN AGGREGATION; PROTEIN DEGRADATION; PROTEIN FUNCTION;

4-HYDROXYTAMOXIFEN; AGGREGATES; AUTOPHAGY; CHOLESTEROL; NEURODEGENERATIVE; PRION; PROTEINOPATHIES; TAMOXIFEN; TRAFFICKING; U18666A;

ANIMALS; HUMANS; LYSOSOMES; PRION DISEASES; PRPC PROTEINS; PRPSC PROTEINS; TAMOXIFEN;

EID: 84886932676     PISSN: 19336896     EISSN: 1933690X     Source Type: Journal    
DOI: 10.4161/pri.25809     Document Type: Article

References (30)

1. Cherra SJ 3rd, Dagda RK, Chu CT. Review: autophagy and neurodegeneration: survival at a cost? Neuropathol Appl Neurobiol 2010; 36:125-32; PMID:20202120
2. Yao H, Zhao D, Khan SH, Yang L. Role of autophagy in prion protein-induced neurodegenerative diseases. Acta Biochim Biophys Sin (Shanghai) 2013; 45:494-502; PMID:23459558; http://dx.doi.org/10.1093/abbs/gmt022
3. Knaevelsrud H, Simonsen A. Fighting disease by selective autophagy of aggregate-prone proteins. FEBS Lett 2010; 584:2635-45; PMID:20412801; http://dx.doi.org/10.1016/j.febslet.2010.04.041
4. Hara T, Nakamura K, Matsui M, Yamamoto A, Nakahara Y, Suzuki-Migishima R, et al. Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature 2006; 441:885-9; PMID:16625204; http://dx.doi.org/10. 1038/nature04724
5. Komatsu M, Waguri S, Chiba T, Murata S, Iwata J, Tanida I, et al. Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature 2006; 441:880-4; PMID:16625205; http://dx.doi.org/10.1038/nature04723
6. Wang J, Ho L, Qin W, Rocher AB, Seror I, Humala N, et al. Caloric restriction attenuates beta-amyloid neuropathology in a mouse model of Alzheimer's disease. FASEB J 2005; 19:659-61; PMID:15650008
7. Prusiner SB. Prions. Proc Natl Acad Sci U S A 1998; 95:13363-83; PMID:9811807; http://dx.doi.org/10.1073/pnas.95.23.13363
8. Kaushik S, Bandyopadhyay U, Sridhar S, Kiffin R, Martinez-Vicente M, Kon M, et al. Chaperonemediated autophagy at a glance. J Cell Sci 2011; 124:495-9; PMID:21282471; http://dx.doi.org/10.1242/jcs.073874
9. Heiseke A, Aguib Y, Schatzl HM. Autophagy, prion infection and their mutual interactions. Curr Issues Mol Biol 2010; 12:87-97; PMID:19767652
10. Schätzl HM, Laszlo L, Holtzman DM, Tatzelt J, DeArmond SJ, Weiner RI, et al. A hypothalamic neuronal cell line persistently infected with scrapie prions exhibits apoptosis. J Virol 1997; 71:8821-31; PMID:9343242
11. Liberski PP, Brown DR, Sikorska B, Caughey B, Brown P. Cell death and autophagy in prion diseases (transmissible spongiform encephalopathies). Folia Neuropathol 2008; 46:1-25; PMID:18368623
12. Sikorska B, Liberski PP, Giraud P, Kopp N, Brown P. Autophagy is a part of ultrastructural synaptic pathology in Creutzfeldt-Jakob disease: a brain biopsy study. Int J Biochem Cell Biol 2004; 36:2563-73; PMID:15325593; http://dx.doi.org/10.1016/j.biocel. 2004.04.014
13. Liberski PP, Jeffrey M. Tubulovesicular structures-the ultrastructural hallmark for transmissible spongiform encephalopathies or prion diseases. Folia Neuropathol 2004; 42(Suppl B):96-108; PMID:16903145
14. Marzo L, Marijanovic Z, Browman D, Chamoun Z, Caputo A, Zurzolo C. 4-hydroxytamoxifen leads to PrPSc clearance by conveying both PrPC and PrPSc to lysosomes independently of autophagy. J Cell Sci 2013; 126:1345-54; PMID:23418355; http://dx.doi.org/10.1242/jcs.114801
15. Kimura S, Fujita N, Noda T, Yoshimori T. Monitoring autophagy in mammalian cultured cells through the dynamics of LC3. Methods Enzymol 2009; 452:1-12; PMID:19200872; http://dx.doi.org/10.1016/S0076-6879(08)03601-X
16. Mitra S, Tsvetkov AS, Finkbeiner S. Protein turnover and inclusion body formation. Autophagy 2009; 5:1037-8; PMID:19838079; http://dx.doi.org/10.4161/ auto.5.7.9291
17. Son JH, Shim JH, Kim KH, Ha JY, Han JY. Neuronal autophagy and neurodegenerative diseases. Exp Mol Med 2012; 44:89-98; PMID:22257884; http://dx.doi.org/10.3858/emm.2012.44.2.031
18. Bursch W, Ellinger A, Kienzl H, Török L, Pandey S, Sikorska M, et al. Active cell death induced by the anti-estrogens tamoxifen and ICI 164 384 in human mammary carcinoma cells (MCF-7) in culture: the role of autophagy. Carcinogenesis 1996; 17:1595-607; PMID:8761415; http://dx.doi.org/10.1093/ carcin/17.8.1595
19. Cho KS, Yoon YH, Choi JA, Lee SJ, Koh JY. Induction of autophagy and cell death by tamoxifen in cultured retinal pigment epithelial and photoreceptor cells. Invest Ophthalmol Vis Sci 2012; 53:5344-53; PMID:22786900; http://dx.doi.org/10.1167/iovs.12-9827
20. de Medina P, Payré B, Boubekeur N, Bertrand-Michel J, Tercé F, Silvente-Poirot S, et al. Ligands of the antiestrogen-binding site induce active cell death and autophagy in human breast cancer cells through the modulation of cholesterol metabolism. Cell Death Differ 2009; 16:1372-84; PMID:19521424; http://dx.doi.org/10.1038/cdd.2009.62
21. Peters PJ, Mironov A Jr., Peretz D, van Donselaar E, Leclerc E, Erpel S, et al. Trafficking of prion proteins through a caveolae-mediated endosomal pathway. J Cell Biol 2003; 162:703-17; PMID:12925711; http://dx.doi.org/10.1083/ jcb.200304140
22. Lewis V, Hooper NM. The role of lipid rafts in prion protein biology. Front Biosci 2011; 16:151-68; PMID:21196164; http://dx.doi.org/10.2741/3681
23. Marijanovic Z, Caputo A, Campana V, Zurzolo C. Identification of an intracellular site of prion conversion. PLoS Pathog 2009; 5:e1000426; PMID:19424437; http://dx.doi.org/10.1371/journal. ppat.1000426
24. Hagiwara K, Nakamura Y, Nishijima M, Yamakawa Y. Prevention of prion propagation by dehydrocholesterol reductase inhibitors in cultured cells and a therapeutic trial in mice. Biol Pharm Bull 2007; 30:835-8; PMID:17409533; http://dx.doi.org/10.1248/bpb.30.835
25. Klingenstein R, Löber S, Kujala P, Godsave S, Leliveld SR, Gmeiner P, et al. Tricyclic antidepressants, quinacrine and a novel, synthetic chimera thereof clear prions by destabilizing detergentresistant membrane compartments. J Neurochem 2006; 98:748-59; PMID:16749906; http://dx.doi.org/10.1111/j.1471- 4159.2006.03889.x
26. Naslavsky N, Shmeeda H, Friedlander G, Yanai A, Futerman AH, Barenholz Y, et al. Sphingolipid depletion increases formation of the scrapie prion protein in neuroblastoma cells infected with prions. J Biol Chem 1999; 274:20763-71; PMID:10409615; http://dx.doi.org/10.1074/jbc.274.30.20763
27. Mok SWF, Thelen KM, Riemer C, Bamme T, Gültner S, Lütjohann D, et al. Simvastatin prolongs survival times in prion infections of the central nervous system. Biochem Biophys Res Commun 2006; 348:697-702; PMID:16890918; http://dx.doi.org/10.1016/j.bbrc.2006.07.123
28. Cenedella RJ. Cholesterol synthesis inhibitor U18666A and the role of sterol metabolism and trafficking in numerous pathophysiological processes. Lipids 2009; 44:477-87; PMID:19440746; http://dx.doi.org/10.1007/s11745-009- 3305-7
29. Arthur JR, Heinecke KA, Seyfried TN. Filipin recognizes both GM1 and cholesterol in GM1 gangliosidosis mouse brain. J Lipid Res 2011; 52:1345-51; PMID:21508255; http://dx.doi.org/10.1194/jlr. M012633
30. Peri A, Benvenuti S, Luciani P, Deledda C, Cellai I. Membrane cholesterol as a mediator of the neuroprotective effects of estrogens. Neuroscience 2011; 191:107-17; PMID:21396986; http://dx.doi.org/10.1016/j.neuroscience.2011.03.011